DeepNewz, mobile.

People-sourced. AI-powered. Unbiased News.

Screenshot of DeepNewz app showing story detail view.

Screenshot of DeepNewz app showing story list view.

Investigational Device Exemption News

TransMedics Beats Q2 Estimates, Lifts 2025 Outlook After FDA Lung-Trial Nod

Company Earnings

TransMedics Beats Q2 Estimates, Lifts 2025 Outlook After FDA Lung-Trial Nod

7

3 days ago

Will Neuralink's PRIME study report any unanticipated adverse device reactions?

Jan 31, 8:39 PMJan 2, 7:59 AM

60.61%chance

17461

OptionVotes

YES

NO

1173

596

Latest stories

Jul 30, 2025
Jul 30, 2025
Company Earnings
Health
Business
TransMedics Beats Q2 Estimates, Lifts 2025 Outlook After FDA Lung-Trial Nod
Authors
7
3 days ago

Join our channels

Get the latest stories live on any device.

WhatsApp
Top Stories
Join
Telegram
Top Stories
Join